Tag: MDC
Medlab’s NanaBis spray deemed safe for chronic pain management in patients with advanced breast and prostate cancers
Results from an advanced cancer pain clinical trial using NanaBis oro-buccal spray developed by Medlab Clinical (ASX: MDC) has found the novel drug candidate to be safe, tolerable and fast-acting with...
Medlab trial shows Nanostat spray delivers improved metabolic functioning over tablet version
Australian-based Medlab Clinical (ASX: MDC) has reported results of a bioequivalence trial involving an orobuccal spray version of its Nanostat cardiovascular medication which have indicated improved ...
Export licence granted to Medlab in development of cannabis pain management products
Australian life sciences company Medlab Clinical (ASX: MDC) has been granted a licence to export cannabis relating to the development of its NanaBis and NanaBidial cancer pain management medications.
...
Medlab Clinical gets positive feedback from doctors prescribing cannabis for cancer pain
Medlab Clinical (ASX: MDC) has claimed it has received positive feedback from doctors prescribing its cannabis-based medicine NanaBis for the pain management of cancer patients.
The Australian medi...
